Market Place
Sourcing Support
Forte Biosciences to Host R&D Day December 3, 2024
25 Nov 2024 //
BUSINESSWIRE
Forte Biosciences Announces $53M Private Placement to Advance FB102
20 Nov 2024 //
BUSINESSWIRE
Forte Biosciences Announces Q3 2024 Results & Updates
14 Nov 2024 //
BUSINESSWIRE
Forte Biosciences Announces Q2 2024 Results And Business Update
14 Aug 2024 //
BUSINESSWIRE
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
17 May 2024 //
BUSINESSWIRE
Forte Biosciences Announces Q1 2024 Results, Business Update
13 May 2024 //
BUSINESSWIRE
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
18 Mar 2024 //
BUSINESSWIRE
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
01 Dec 2023 //
BUSINESSWIRE
Forte Bio Announces Third Quarter 2023 Results and Provides Business Update
13 Nov 2023 //
BUSINESSWIRE
Forte Biosciences, Inc. Announces Second Quarter 2023 Results
14 Aug 2023 //
BUSINESSWIRE
Forte Biosciences Announces $25 Million Financing and R&D Update for FB-102
01 Aug 2023 //
BUSINESSWIRE
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
19 May 2023 //
BUSINESSWIRE
Forte Biosciences, Inc. Announces 1Q 2023 Results & Provides Business Update
15 May 2023 //
BUSINESSWIRE
Forte Biosciences Announces Full Year 2022 Results and Provides Business Update
31 Mar 2023 //
BUSINESSWIRE
Mr. David Gryska Appointed to Forte Biosciences Board of Directors
12 Jan 2023 //
BUSINESSWIRE
Scott Brun Appointed to Forte Biosciences Board of Directors
14 Nov 2022 //
BUSINESSWIRE
Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors
14 Nov 2022 //
BUSINESSWIRE
Forte Biosciences, Inc. Announces Third Quarter 2022 Results
14 Nov 2022 //
BUSINESSWIRE
Forte Biosciences, Inc. Announces Second Quarter 2022 Results
15 Aug 2022 //
BUSINESSWIRE
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
07 Jun 2022 //
BUSINESSWIRE
Forte Biosciences Appoints Dr. Hubert Chen, MD as CSO and President
07 Jun 2022 //
BUSINESSWIRE
Forte`s top shareholder calls on the company to liquidate
25 May 2022 //
FIERCEBIOTECH
Forte Biosciences Announces First Quarter 2022 Results
16 May 2022 //
BUSINESSWIRE
Denovo Announces Breakthrough Discovery of DB107 for Gene Therapy-Based Medicine
16 Dec 2021 //
PRNEWSWIRE
Forte (FBRX) Posts Dismal Data on Atopic Dermatitis Candidate
03 Sep 2021 //
ENTREPRENEUR
Forte (FBRX) Posts Dismal Data on Atopic Dermatitis Candidate
03 Sep 2021 //
ENTREPRENEUR
Forte Biosciences shares collapse after lead bacteria drug flops key eczema study
03 Sep 2021 //
ENDPTS
Forte Biosciences shares collapse after lead bacteria drug flops eczema study
02 Sep 2021 //
ENDPTS
Forte Biosciences, Inc. to Review the Second Quarter 2021 Results
16 Aug 2021 //
BUSINESSWIRE
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
02 Aug 2021 //
BUSINESS WIRE
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
12 Jul 2021 //
BUSINESSWIRE
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
01 Jul 2021 //
BUSINESSWIRE
Forte Biosciences to Announce First Quarter 2021 Results
03 May 2021 //
BUSINESSWIRE
Forte Biosciences Announces Closing of $46.0 M Public Offering of Common Stock
02 Nov 2020 //
BUSINESSWIRE
Forte Biosciences Announces Pricing of $40.0 M Public Offering of Common Stock
30 Oct 2020 //
BUSINESSWIRE
Forte Announces the FDA Has Granted Fast Track Designation to FB-401
26 Oct 2020 //
BUSINESSWIRE
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
15 Oct 2020 //
BUSINESSWIRE
Dosing underway for Forte Biosciences`s lead asset mid-stage atopic dermatitis
29 Sep 2020 //
SEEKING ALPHA
Forte Biosciences Announces 1st Patient Dosed in the Clinical Trial of FB-401
29 Sep 2020 //
BUSINESSWIRE
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
27 Jul 2020 //
BUSINESSWIRE
Forte Biosciences, Inc. Announces Issuance of New U.S. Patent
18 Jun 2020 //
BUSINESS WIRE
Forte Biosciences, Inc. Announces Closing of Merger With Tocagen
15 Jun 2020 //
BUSINESSWIRE
Having sold its corporate self, Tocagen auctions off scientific platform
29 Apr 2020 //
ENDPTS
